NCT06259929
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06259929
Title NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)
Acronym Neo-AGILE
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Fondazione Oncotech
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Humanitas Istituto Clinico Catanese NOT_YET_RECRUITING Catania Catania 95045 Italy Details
IRCCS Ospedale Policlinico San Martino NOT_YET_RECRUITING Genova Genova 16132 Italy Details
AOU Federico II NOT_YET_RECRUITING Napoli Napoli 80131 Italy Details
Istituto Nazionale Tumori "G. Pascale" RECRUITING Napoli Napoli 80131 Italy Details
Istituto Oncologico Veneto IRCCS NOT_YET_RECRUITING Padua Padova 35128 Italy Details
IRCCS Centro di Riferimento Oncologico (CRO) NOT_YET_RECRUITING Aviano PN 33081 Italy Details
Fondazione Universitaria Policlinico Gemelli IRCCS NOT_YET_RECRUITING Roma Roma 00168 Italy Details
Ospedale Fatebenefratelli - Isola Tiberina NOT_YET_RECRUITING Roma Roma 00186 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field